Position in DGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$8,396,611
+$1,091,653 QoQ
Shares Held
39,616
+6.3% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#181
of 1,090 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $179,401,377 across 25 Diagnostics & Research names. DGX ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
109,972 | $55,135,561 | |
| 2 | DHR |
Danaher Corp /De/
|
139,533 | $26,578,245 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
117,365 | $22,677,265 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
22,840 | $12,023,889 | |
| 5 | LH |
Labcorp Holdings Inc.
|
32,320 | $9,049,600 | |
| 6 | DGX |
Quest Diagnostics Inc
This page
|
39,616 | $8,396,611 | |
| 7 | NTRA |
Natera, Inc.
|
27,675 | $7,512,378 | |
| 8 | A |
Agilent Technologies, Inc.
|
48,741 | $6,474,267 |
All Filings in DGX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,396,611 | 39,616 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $7,304,958 | 37,274 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,017,099 | 28,912 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,584,565 | 29,303 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,282,558 | 23,841 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,892,615 | 23,006 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,775,673 | 18,399 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,629,469 | 16,937 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,207,190 | 16,125 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $2,114,053 | 15,882 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $514,016 | 3,728 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $610,640 | 5,011 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $940,908 | 6,694 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $944,661 | 6,677 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,321,761 | 8,449 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $256,176 | 2,088 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $476,334 | 3,582 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $494,612 | 3,614 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,357,436 | 7,846 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,300,960 | 8,953 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,015,377 | 7,694 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $968,068 | 7,543 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $663,776 | 5,570 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||